Literature DB >> 12663799

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.

Anding Shen1, M Christine Zink, Joseph L Mankowski, Karen Chadwick, Joseph B Margolick, Lucy M Carruth, Ming Li, Janice E Clements, Robert F Siliciano.   

Abstract

Despite suppression of viremia in patients on highly active antiretroviral therapy (HAART), human immunodeficiency virus type 1 persists in a latent reservoir in the resting memory CD4(+) T lymphocytes and possibly in other reservoirs. To better understand the mechanisms of viral persistence, we established a simian immunodeficiency virus (SIV)-macaque model to mimic the clinical situation of patients on suppressive HAART and developed assays to detect latently infected cells in the SIV-macaque system. In this model, treatment of SIV-infected pig-tailed macaques (Macaca nemestrina) with the combination of 9-R-(2-phosphonomethoxypropyl)adenine (PMPA; tenofovir) and beta-2',3'-dideoxy-3'-thia-5-fluorocytidine (FTC) suppressed the levels of plasma virus to below the limit of detection (100 copies of viral RNA per ml). In treated animals, levels of viremia remained close to or below the limit of detection for up to 6 months except for an isolated "blip" of detectable viremia in each animal. Latent virus was measured in blood, spleen, lymph nodes, and thymus by several different methods. Replication-competent virus was recovered after activation of a 99.5% pure population of resting CD4(+) T lymphocytes from a lymph node of a treated animal. Integrated SIV DNA was detected in resting CD4(+) T cells from spleen, peripheral blood, and various lymph nodes including those draining the gut, the head, and the limbs. In contrast to the wide distribution of latently infected cells in peripheral lymphoid tissues, neither replication-competent virus nor integrated SIV DNA was detected in thymocytes, suggesting that thymocytes are not a major reservoir for virus in pig-tailed macaques. The results provide the first evidence for a latent viral reservoir for SIV in macaques and the most extensive survey of the distribution of latently infected cells in the host.

Entities:  

Mesh:

Year:  2003        PMID: 12663799      PMCID: PMC152116          DOI: 10.1128/jvi.77.8.4938-4949.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Generation of HIV latency during thymopoiesis.

Authors:  D G Brooks; S G Kitchen; C M Kitchen; D D Scripture-Adams; J A Zack
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

Review 2.  The challenge of viral reservoirs in HIV-1 infection.

Authors:  Joel N Blankson; Deborah Persaud; Robert F Siliciano
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Authors:  D V Havlir; R Bassett; D Levitan; P Gilbert; P Tebas; A C Collier; M S Hirsch; C Ignacio; J Condra; H F Günthard; D D Richman; J K Wong
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  Evidence for increased T cell turnover and decreased thymic output in HIV infection.

Authors:  D C Douek; M R Betts; B J Hill; S J Little; R Lempicki; J A Metcalf; J Casazza; C Yoder; J W Adelsberger; R A Stevens; M W Baseler; P Keiser; D D Richman; R T Davey; R A Koup
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

Authors:  B Ramratnam; J E Mittler; L Zhang; D Boden; A Hurley; F Fang; C A Macken; A S Perelson; M Markowitz; D D Ho
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

6.  Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Authors:  J Kulkosky; D M Culnan; J Roman; G Dornadula; M Schnell; M R Boyd; R J Pomerantz
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

7.  Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

Authors:  J R Taylor; K C Kimbrell; R Scoggins; M Delaney; L Wu; D Camerini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation.

Authors:  A Jordan; P Defechereux; E Verdin
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

9.  Thymus in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  G B Baskin; M Murphey-Corb; L N Martin; B Davison-Fairburn; F S Hu; D Kuebler
Journal:  Lab Invest       Date:  1991-10       Impact factor: 5.662

10.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Authors:  M I Bukrinsky; T L Stanwick; M P Dempsey; M Stevenson
Journal:  Science       Date:  1991-10-18       Impact factor: 63.714

View more
  70 in total

Review 1.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

2.  Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection.

Authors:  Christopher W Peterson; Patrick Younan; Patricia S Polacino; Nicholas J Maurice; Hannah W Miller; Martin Prlic; Keith R Jerome; Ann E Woolfrey; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  J Med Primatol       Date:  2013-10       Impact factor: 0.667

3.  Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.

Authors:  Dongzhu Ma; Cuiling Xu; Anthony R Cillo; Benjamin Policicchio; Jan Kristoff; George Haret-Richter; John W Mellors; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 4.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

5.  Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.

Authors:  Jamie L Schafer; Haiying Li; Tristan I Evans; Jacob D Estes; R Keith Reeves
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

6.  A quantitative measurement of antiviral activity of anti-human immunodeficiency virus type 1 drugs against simian immunodeficiency virus infection: dose-response curve slope strongly influences class-specific inhibitory potential.

Authors:  Kai Deng; M Christine Zink; Janice E Clements; Robert F Siliciano
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

Review 7.  Therapy for persistent HIV.

Authors:  Kara S Keedy; David M Margolis
Journal:  Trends Pharmacol Sci       Date:  2010-03-05       Impact factor: 14.819

Review 8.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

9.  Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection.

Authors:  Adriano Boasso; Monica Vaccari; Anna Hryniewicz; Dietmar Fuchs; Janos Nacsa; Valentina Cecchinato; Jan Andersson; Genoveffa Franchini; Gene M Shearer; Claire Chougnet
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Coordinated regulation of SIV replication and immune responses in the CNS.

Authors:  Kenneth W Witwer; Lucio Gama; Ming Li; Christopher M Bartizal; Suzanne E Queen; John J Varrone; Angela K Brice; David R Graham; Patrick M Tarwater; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.